It looks like the final round of Emergent's AstraZeneca Covid-19 doses have been released
Four more batches of AstraZeneca’s Covid-19 vaccine that were made at Emergent BioSolutions’ Baltimore plant have been cleared for shipment outside the US by the FDA, but it seems like this will be the last round of updates the agency is providing in connection to the quarantined doses from the CDMO, wrapping up a nearly one-year saga that led to the tossing of millions of Covid-19 doses.
The FDA disclosed the news in its roundup on Friday, but did not make Emergent aware of the news, a spokesperson told Endpoints News in an email Tuesday. In the roundup, the agency said:
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
